Literature DB >> 27323014

Effect of ozone on vascular endothelial growth factor (VEGF) and related inflammatory cytokines in rats with diabetic retinopathy.

T Y Xie1, W Yan1, J Lou1, X Y Chen1.   

Abstract

The aim of this study was to investigate the effect of ozone on inflammatory cytokines in diabetic retinopathy (DR) rats. Male rats (40) weighing 300-360 g were included in this study. Thirty rats were randomly divided into the model and ozone groups after DR was induced by streptozotocin. Ten rats served as the blank group. After the diabetic models were established for one month, the rats in the ozone group were treated with 50 mg/kg ozone coloclysis for one month (three times a week). After the rats were anesthetized by intraperitoneal injection, blood samples from the abdominal aorta were collected, and the supernatant was obtained by centrifugation. Vascular endothelial growth factor (VEGF) and inflammatory cytokine content in the serum was detected by enzyme linked immunosorbent assay. The values of VEGF, intercellular cell adhesion molecule-1, interleukin-1 beta, tumor necrosis factor-a, and IL-6 were significantly different among the three groups (P < 0.05). The cytokine levels in the model group were higher than those in the blank group (P < 0.05). The level of each cytokine in the ozone group was higher than that in the blank group. Compared with the model group, the cytokine levels in the ozone group were significantly reduced (P < 0.05). Ozone had no effect on the blood glucose of diabetic rats. Treatment with ozone coloclysis may effectively reduce the secretion of VEGF and inflammatory cytokines in diabetic retinopathy rats.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27323014     DOI: 10.4238/gmr.15027558

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

1.  The effect of ozone on hypoxia, hemolysis and morphological change of blood from patients with aortic dissection (AD): a preliminary in vitro experiment of ozonated autohemotherapy for treating AD.

Authors:  Li Deng; Weixin Meng; Dandan Li; Dongyun Qiu; Siqing Wang; Hongyu Liu
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

Review 2.  Oxygen-Ozone Therapy in the Rehabilitation Field: State of the Art on Mechanisms of Action, Safety and Effectiveness in Patients with Musculoskeletal Disorders.

Authors:  Alessandro de Sire; Francesco Agostini; Lorenzo Lippi; Massimiliano Mangone; Simone Marchese; Carlo Cisari; Andrea Bernetti; Marco Invernizzi
Journal:  Biomolecules       Date:  2021-02-26

3.  Interindividual Heterogeneity of Hypoxic Response of Vascular Endothelial Growth Factor and Intercellular Adhesive Molecule-1 in Monocytes from Diabetic Patients.

Authors:  Zhi-Kun Yang; Zhuo-Zai Xu; Xiao Zhang; Fei Gao; Wei-Hong Yu
Journal:  Chin Med J (Engl)       Date:  2016-12-05       Impact factor: 2.628

Review 4.  The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure.

Authors:  Mirco Galiè; Viviana Covi; Gabriele Tabaracci; Manuela Malatesta
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

Review 5.  Oxygen-Ozone Therapy for Reducing Pro-Inflammatory Cytokines Serum Levels in Musculoskeletal and Temporomandibular Disorders: A Comprehensive Review.

Authors:  Alessandro de Sire; Nicola Marotta; Martina Ferrillo; Francesco Agostini; Cristiano Sconza; Lorenzo Lippi; Stefano Respizzi; Amerigo Giudice; Marco Invernizzi; Antonio Ammendolia
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

6.  Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.

Authors:  Guotao Deng; Elizabeth P Moran; Rui Cheng; Greg Matlock; Kelu Zhou; David Moran; Danyang Chen; Qiang Yu; Jian-Xing Ma
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.